1-9 of 9
Geertruida H. de Bock
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Value of Glycemic Control Prior to Cancer Diagnosis on All-Cause Mortality among Patients with Type 2 Diabetes in Dutch Primary Care

Jing de Haan-Du, Klaas H. Groenier, Brendy Wauben-Spaetgens, Mathilde Jalving, Nanne Kleefstra, Gijs W.D. Landman, Geertruida H. de Bock
Journal: Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiol Biomarkers Prev (2023) 32 (2): 252–259.
https://doi.org/10.1158/1055-9965.EPI-22-0766
Published: 06 February 2023
View article titled, The Value of Glycemic Control Prior to Cancer Diagnosis on All-Cause Mortality among Patients with Type 2 Diabetes in Dutch Primary Care
Open the PDF for The Value of Glycemic Control Prior to Cancer Diagnosis on All-Cause Mortality among Patients with Type 2 Diabetes in Dutch Primary Care in another window
Includes: Supplementary data
Journal Articles

Airflow Limitation Increases Lung Cancer Risk in Smokers: The Lifelines Cohort Study

Yihui Du, Grigory Sidorenkov, Harry J.M. Groen, Marjolein A. Heuvelmans, Rozemarijn Vliegenthart, Monique D. Dorrius, Wim Timens, Geertruida H. de Bock
Journal: Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiol Biomarkers Prev (2022) 31 (7): 1442–1449.
https://doi.org/10.1158/1055-9965.EPI-21-1365
Published: 01 July 2022
View article titled, Airflow Limitation Increases Lung Cancer Risk in Smokers: The Lifelines Cohort Study
Open the PDF for Airflow Limitation Increases Lung Cancer Risk in Smokers: The Lifelines Cohort Study in another window
Includes: Supplementary data
Journal Articles

The Risk of Cutaneous Squamous Cell Carcinoma Among Patients with Type 2 Diabetes Receiving Hydrochlorothiazide: A Cohort Study

Jing de Haan-Du, Gijs W.D. Landman, Klaas H. Groenier, Pauline A.J. Vissers, Marieke W.J. Louwman, Nanne Kleefstra, Geertruida H. de Bock
Journal: Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiol Biomarkers Prev (2021) 30 (11): 2114–2121.
https://doi.org/10.1158/1055-9965.EPI-21-0620
Published: 01 November 2021
View article titled, The Risk of Cutaneous Squamous Cell Carcinoma Among Patients with Type 2 Diabetes Receiving Hydrochlorothiazide: A Cohort Study
Open the PDF for The Risk of Cutaneous Squamous Cell Carcinoma Among Patients with Type 2 Diabetes Receiving Hydrochlorothiazide: A Cohort Study in another window
Includes: Supplementary data
Journal Articles

Is Gliclazide Associated with a Lower Obesity-Related Cancer Risk Compared to Other Sulfonylureas? A Long-term Prospective Cohort Study

Jing Du, Nanno Kleefstra, Dennis Schrijnders, Klaas H. Groenier, Geertruida H. de Bock, Gijs W.D. Landman
Journal: Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiol Biomarkers Prev (2020) 29 (8): 1596–1605.
https://doi.org/10.1158/1055-9965.EPI-19-1517
Published: 03 August 2020
View article titled, Is Gliclazide Associated with a Lower Obesity-Related Cancer Risk Compared to Other Sulfonylureas? A Long-term Prospective Cohort Study
Open the PDF for Is Gliclazide Associated with a Lower Obesity-Related Cancer Risk Compared to Other Sulfonylureas? A Long-term Prospective Cohort Study in another window
Includes: Supplementary data
Journal Articles

The BRCA1/2 Parent-of-Origin Effect on Breast Cancer Risk—Response

Janet R. Vos, Jan C. Oosterwijk, Matti A. Rookus, Annemarie H. van der Hout, Marian J. Mourits, Geertruida H. de Bock
Journal: Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiol Biomarkers Prev (2017) 26 (2): 285.
https://doi.org/10.1158/1055-9965.EPI-16-0947
Published: 05 February 2017
View article titled, The <em>BRCA1/2</em> Parent-of-Origin Effect on Breast Cancer Risk—Response
Open the PDF for The <em>BRCA1/2</em> Parent-of-Origin Effect on Breast Cancer Risk—Response in another window
Journal Articles

Bias Explains Most of the Parent-of-Origin Effect on Breast Cancer Risk in BRCA1/2 Mutation Carriers

Janet R. Vos, Jan C. Oosterwijk, Cora M. Aalfs, Matti A. Rookus, Muriel A. Adank, Annemarie H. van der Hout, Christi J. van Asperen, Encarna B. Gómez Garcia, Arjen R. Mensenkamp, Agnes Jager, Margreet G.E.M. Ausems, Marian J. Mourits, Geertruida H. de Bock
Journal: Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiol Biomarkers Prev (2016) 25 (8): 1251–1258.
https://doi.org/10.1158/1055-9965.EPI-16-0182
Published: 31 July 2016
View article titled, Bias Explains Most of the Parent-of-Origin Effect on Breast Cancer Risk in <em>BRCA1/2</em> Mutation Carriers
Open the PDF for Bias Explains Most of the Parent-of-Origin Effect on Breast Cancer Risk in <em>BRCA1/2</em> Mutation Carriers in another window
Includes: Supplementary data
Journal Articles

Variation in Mutation Spectrum Partly Explains Regional Differences in the Breast Cancer Risk of Female BRCA Mutation Carriers in the Netherlands

Janet R. Vos, Natalia Teixeira, Dorina M. van der Kolk, Marian J.E. Mourits, Matti A. Rookus, Flora E. van Leeuwen, Margriet Collée, Christi J. van Asperen, Arjen R. Mensenkamp, Margreet G.E.M. Ausems, Theo A.M. van Os, Hanne E.J. Meijers-Heijboer, Encarna B. Gómez-Garcia, Hans F. Vasen, Richard M. Brohet, on behalf of the Hereditary Breast and Ovarian Cancer Research Group Netherlands, Annemarie H. van der Hout, Liesbeth Jansen, Jan C. Oosterwijk, Geertruida H. de Bock
Journal: Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiol Biomarkers Prev (2014) 23 (11): 2482–2491.
https://doi.org/10.1158/1055-9965.EPI-13-1279
Published: 02 November 2014
View article titled, Variation in Mutation Spectrum Partly Explains Regional Differences in the Breast Cancer Risk of Female <em>BRCA</em> Mutation Carriers in the Netherlands
Open the PDF for Variation in Mutation Spectrum Partly Explains Regional Differences in the Breast Cancer Risk of Female <em>BRCA</em> Mutation Carriers in the Netherlands in another window
Includes: Supplementary data
Journal Articles

Breast Cancer Screening, Outside the Population-Screening Program, of Women from Breast Cancer Families without Proven BRCA1/BRCA2 Mutations: a Simulation Study

Catharina E. Jacobi, Nico J.D. Nagelkerke, J. (Hans) C. van Houwelingen, Geertruida H. de Bock
Journal: Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiol Biomarkers Prev (2006) 15 (3): 429–436.
https://doi.org/10.1158/1055-9965.EPI-05-0223
Published: 14 March 2006
View article titled, Breast Cancer Screening, Outside the Population-Screening Program, of Women from Breast Cancer Families without Proven BRCA1/BRCA2 Mutations: a Simulation Study
Open the PDF for Breast Cancer Screening, Outside the Population-Screening Program, of Women from Breast Cancer Families without Proven BRCA1/BRCA2 Mutations: a Simulation Study in another window
Journal Articles

Modeling Familial Clustered Breast Cancer Using Published Data

M. A. Jonker, C. E. Jacobi, W. E. Hoogendoorn, N. J. D. Nagelkerke, Geertruida H. de Bock, Johannes C. van Houwelingen
Journal: Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiol Biomarkers Prev (2003) 12 (12): 1479–1485.
Published: 23 December 2003
View article titled, Modeling Familial Clustered Breast Cancer Using Published Data
Open the PDF for Modeling Familial Clustered Breast Cancer Using Published Data in another window